Matt Fornataro

Partner @Arnold & Porter

Washington, DC, US

Matt Fornataro\'s practice focuses on life sciences and health care regulation and public policy matters. Matt specializes in drug pricing and government price reporting, pharmaceutical market access strategies and contracting, and fraud and abuse compliance. He works with established and emerging pharmaceutical, biotechnology, and medical device manufacturers.In his work on government price reporting matters, Matt advises manufacturers on Medicaid, Medicare Part B, Department of Veterans Affairs, and 340B Program requirements, as well as state drug price reporting and transparency laws. He also advises on implementation of the drug pricing provisions of the Inflation Reduction Act of 2022, including supporting manufacturers with data collection and CMS engagement for the Maximum Fair Price program.Matt advises manufacturers on market access strategies and contracting, including advising on fraud and abuse compliance. He addresses questions arising under the federal Anti-Kickback Statute, the False Claims Act, and the Civil Monetary Penalties & Exclusion laws. Matt assists manufacturers with complex risk analyses, internal reviews and investigations, OIG Advisory Opinion requests, product acquisitions and divestitures, and government audits and investigations.He is co-chair of Arnold & Porter\'s Pride Affinity Group and was named by the National LGBT Bar Association as one of its \"Best LGBT Lawyers Under 40\" for his professional accomplishments and pro bono work for causes of importance to the LGBTQ+ community.